November 16, 2022
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Jane Park |
Re: | VectivBio Holding AG |
Registration Statement on Form F-3
Filed November 10, 2022
File No. 333-265546
Acceleration Request
Requested Date: November 18, 2022
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 (File No. 333-265546) (the “Registration Statement”), to become effective on November 18, 2022, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the Commission’s staff. The Registrant hereby authorizes Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Brandon Fenn of Cooley LLP at (212) 479-6626.
[Signature page follows]
Very truly yours, | ||
VectivBio Holding AG | ||
By: | /s/ Luca Santarelli | |
Luca Santarelli | ||
Chief Executive Officer |
cc: | Scott Applebaum, VectivBio Holding AG |
Brandon Fenn, Cooley LLP
Dayne Brown, Cooley LLP
Andreas Müller, Homburger AG